Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5305354 | 0.81 | TAAR1 (0.63) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5473006 | 0.80 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL6284795 | 0.80 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5469153 | 0.80 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5291239 | 0.80 | TAAR1 (0.65) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL30249027 | 0.80 | TAAR1 (0.65) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL2418816 | 0.77 | TAAR1 (0.68) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL29633088 | 0.77 | TAAR1 (0.68) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL25532944 | 0.77 | TAAR1 (0.68) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5471876 | 0.76 | SLC6A4 (0.67) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6946547-B2 | Ecstasy-class analogs and use of same in detection of ecstasy-class compounds | MICROGENICS CORPORATION (US) | 2005-09-20 | — | — | US | disclosed |
| US-20030207469-A1 | Ecstasy-class analogs and use of same in detection of ecstasy-class compounds | MICROGENICS CORPORATION (US) | 2003-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207469-A1 | Ecstasy-class analogs and use of same in detection of ecstasy-class compounds | CES2, DNPEP, HLA-A | TAAR1 359/4885SLC6A4 208/4885SLC6A2 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.